| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -2,2 M € | +9.7% | -2,5 M € | -6.7% | -2,3 M € | -39.2% | -1,7 M € | -50.6% | -1,1 M € | +16.4% | -1,3 M € | -17.6% | -1,1 M € | -49.9% | -753,5 k € | -58.4% | -475,8 k € | -13.5% | -419,1 k € | -66.8% | -251,3 k € | -82.8% | -137,5 k € | -21.3% | -113,3 k € | -392.4% | 38,8 k € | +164.5% | 14,7 k € | +135.1% | -41,8 k € | -86.3% | -22,4 k € | |
| EBITDA | -4,3 M € | +6.1% | -4,6 M € | -11.3% | -4,1 M € | -41.0% | -2,9 M € | -48.0% | -2,0 M € | -4.0% | -1,9 M € | -17.6% | -1,6 M € | -35.9% | -1,2 M € | -44.9% | -818,6 k € | -23.7% | -661,9 k € | -52.2% | -434,8 k € | -44.2% | -301,5 k € | -0.1% | -301,1 k € | -120.1% | -136,8 k € | +34.5% | -208,9 k € | -5.6% | -197,7 k € | -73.8% | -113,8 k € | |
| Operating profit | -5,4 M € | +2.2% | -5,5 M € | -13.0% | -4,9 M € | -38.7% | -3,5 M € | -43.6% | -2,4 M € | -5.5% | -2,3 M € | -14.6% | -2,0 M € | -30.2% | -1,6 M € | -31.6% | -1,2 M € | -19.7% | -984,5 k € | -29.3% | -761,6 k € | -21.4% | -627,5 k € | -4.8% | -598,7 k € | -66.5% | -359,5 k € | +8.7% | -393,8 k € | -45.8% | -270,0 k € | -101.5% | -134,0 k € | |
| Profit/loss | -9,9 M € | -73.2% | -5,7 M € | -17.4% | -4,9 M € | -37.7% | -3,5 M € | -44.6% | -2,5 M € | -7.3% | -2,3 M € | -12.5% | -2,0 M € | -29.5% | -1,6 M € | -32.1% | -1,2 M € | -21.2% | -979,7 k € | -32.2% | -741,0 k € | -14.1% | -649,1 k € | -18.0% | -550,0 k € | -73.3% | -317,5 k € | +8.6% | -347,5 k € | -25.2% | -277,5 k € | -110.7% | -131,7 k € | |
| Equity | -15,1 M € | -193.8% | -5,1 M € | -941.6% | 609,2 k € | -88.9% | 5,5 M € | -6.7% | 5,9 M € | -29.4% | 8,3 M € | +218.7% | 2,6 M € | -43.7% | 4,6 M € | +300.8% | 1,2 M € | -13.7% | 1,3 M € | +120.8% | 608,8 k € | +49.5% | 407,2 k € | -33.7% | 613,8 k € | +2.9% | 596,4 k € | +203.8% | 196,3 k € | +431.8% | -59,2 k € | -127.1% | 218,3 k € | |
| Total assets | 5,1 M € | +6.2% | 4,8 M € | -13.0% | 5,5 M € | -39.5% | 9,1 M € | +1.6% | 9,0 M € | -7.6% | 9,7 M € | +141.8% | 4,0 M € | -32.6% | 6,0 M € | +280.0% | 1,6 M € | -7.9% | 1,7 M € | +61.9% | 1,1 M € | +15.5% | 913,2 k € | -17.2% | 1,1 M € | +60.1% | 688,4 k € | -17.4% | 833,8 k € | +113.4% | 390,7 k € | +52.4% | 256,3 k € | |
| Cash | 216,9 k € | -11.1% | 244,0 k € | -44.9% | 442,7 k € | -92.8% | 6,1 M € | -11.0% | 6,9 M € | -15.3% | 8,2 M € | +211.3% | 2,6 M € | -46.7% | 4,9 M € | +991.5% | 450,5 k € | -43.0% | 790,6 k € | +264.2% | 217,1 k € | +14.6% | 189,4 k € | -42.4% | 328,6 k € | +403.7% | 65,2 k € | +49.1% | 43,8 k € | — | 190,5 k € | |||
| Debts | 20,2 M € | +103.0% | 9,9 M € | +102.0% | 4,9 M € | +34.6% | 3,7 M € | +19.1% | 3,1 M € | +125.7% | 1,4 M € | -0.9% | 1,4 M € | +5.0% | 1,3 M € | +217.3% | 411,4 k € | +13.8% | 361,6 k € | -18.8% | 445,5 k € | -11.9% | 505,9 k € | +3.6% | 488,4 k € | +470.3% | 85,6 k € | -86.5% | 633,7 k € | +41.8% | 446,9 k € | +1077.1% | 38,0 k € | |
| Staff | 19,4 | 21,1 | 16,9 | 11,4 | 8,9 | 6,3 | 5,6 | 5,5 | 4,8 | 3 | 2 | 2 | 2 | 2 | 2,8 | 2,2 | 1,1 | |||||||||||||||||
Public limited company · Charleroi · incorporated on 29/10/2008 · 19,4 ETP
Public limited company loss-making in the latest fiscal year. Cash position declining (-11.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
ENDO TOOLS THERAPEUTICS is a Public limited company incorporated in 2008. Its registered office is in Charleroi. It employs on average 19,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette